Open AccessTBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker
Author(s) -
K. Componeschi,
J. Specht,
N. Tung,
I. Krop,
P.K. Marcom,
A.C. Wolff,
M. Rimawi,
L. Trippa,
T. Traina,
E.L. Mayer,
C. Perou,
V. Abramson,
Z. Tan-Wasielewski,
V. Stearns,
E.P. Winer,
K. Timms,
A.L. Richardson,
C. Falkson,
K. Miller,
L. Carey,
R. Jankowitz
Publication year - 2021
Publication title -
unc libraries
Language(s) - English
DOI - 10.17615/pdj8-zw07
Subject(s) - homologous recombination , cisplatin , breast cancer , biomarker , paclitaxel , triple negative breast cancer , homologous chromosome , oncology , medicine , cancer research , cancer , chemotherapy , biology , gene , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom